ArticleEuropean journal of medical research2025
CAF derived IL-33 mediated EMT to promote the metastasis of LSCC cells.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe metastasis of laryngeal squamous cell carcinoma (LSCC) is not only caused by the tumor itself but is also closely related to cancer-associated fibroblasts (CAFs). The epithelial-mesenchymal transition (EMT) serves as a key event during its metastasis. However, the specific mechanisms underlying LSCC metastasis remain uncertain.
methodsA wound healing assay was utilized to evaluate the migratory capacity of LSCC cells (TU686 and TU212 cells). Immunofluorescence staining and Western blot analysis were conducted to demonstrate the expression levels of associated proteins. Migration and invasion assays were employed to assess the migration and invasion abilities of LSCC cells in vitro. A nude mouse metastasis model was used to detect LSCC metastasis in vivo.
resultsOur results revealed that interleukin-33 (IL-33) enhanced the migratory, invasive, and EMT capabilities of LSCC cells. In the co-culture model of LSCC cells and CAFs, silencing the expression of IL-33 inhibited the migratory, invasive, and metastasis potential of LSCC cells both in vitro and in vivo.
conclusionIL-33 derived from CAFs mediates EMT to promote the metastasis of LSCC cells. The findings of our study not only provide a new mechanism for the activation of CAFs and the metastasis of LSCC but also offer theoretical significance and application value for more effective prevention and treatment strategies in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.